A propos de votre organisation

We developed the technology initially focused on diabetes but we built it modular to easily adapt it to other diseases like epilepsy, high blood pressure and anti-clotting as examples.

Our learning algorithm in the cloud receives information from the third party wearable devices that the patients currently use (continuous glucose monitors and smartwatches), and with that information, it is able to represent on the Smartphone app the predicted future glucose levels and recommended actions to avoid risk (for example, a notification will be sent if the system detects a low glucose risk, with a snack recommendation; or the patient could ask how drinking a coke in 30 minutes or going for a hike will afect their future glucose level). After testing it the error is less tan 10 glucose units when forecasting 1 hour glucose.

 

With all this information, the system will very soon be able to calculate the optimal insulin dose so we built a working prototype of the insulin smartpatch and designed the functionalities according to the user needs (for example modularity for easy refill, it is comfortable, discrete and safe). We tested it in 2016 and we managed to get drugs through the skin without any kind of needles. We already have an improved prototype to be tested in laboratory during May.

Actualités

Recherche de partenaires

Voir les informations détaillées

Technological partner

Type de partenariat
Demande
Objet du partenariat
Technologique
Marchés
Royaume-Uni

+ 2

Pharmaceutical partner

Type de partenariat
Demande
Objet du partenariat
Industriel
Marchés
Royaume-Uni

+ 2

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Activité récente

Vous n'êtes pas connecté(e)

Un certain nombre de contenus vous sont cachés et vous ne bénéficiez pas des fonctionnalités de mises en relation.

Log in or register pour accéder à l’intégralité des contenus et fonctionnalités d’EuroQuity : l’inscription est rapide et gratuite !